investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Development of Low-Cost HPV Vaccine and WHO PQ [PDW]
Andrew Wong
0 Collaborator(s)
Funding source
Bill & Melinda Gates Foundation
Follow
+ Project
+ Post
+ Event
Info
People
Posts
to improve women's access to low-cost bivalent HPV vaccine in GAVI-supported countries
Related projects
Investigator from Fred Hutchinson Cancer Research Center
Cervical Cancer Vaccine
Cervix uteri
Umesh Shaligram
Development of HPV Vaccine
Cervix uteri
Anna R Giuliano
Research Training in Cancer Prevention and Control in Morocco
Cervix uteri
Breast
All cancers but non-melanoma skin cancer
Global Noncommunicable Diseases Intiatives
NVS
Cervix uteri
Global Noncommunicable Diseases Intiatives
Improving sexual and reproductive health care of Paraguayan women supporting the National Plan on cervical cancer prevention, Ministry of Public Health
Cervix uteri
Josaphat Byamugisha
BILATERAL RESEARCH COOPERATION WITH UGANDA: Sub-Program: Reproductive Health and Child Survival
Cervix uteri
Tzyy-Choou Wu
SPORE in Cervical Cancer - Project 5: A Phase I Safety and Immunogenicity Study of a HP16- Specific Therapeutic Protein, TA-CIN, Administered Intratumorally During Chemoradiation, in Patients with Inoperable HPV16+ Cervical Cancer
Cervix uteri
Radiation Oncology
Mark Schiffman
HPV Guanacaste Study- infection and cervical neoplasia in a high-risk area (Costa Rica)
Cervix uteri
Investigator from PathoFinder (Netherlands)
Early diagnosis of cervical cancer through the validation of Human Papilloma Virus viral load and expression of oncogenic viral proteins E6/E7 as risk indicators
Cervix uteri
